earlier launch ingeniorx acceler growth broader
govern model ep think
full benefit pbm begin hit segment
bottom line remain top pick pt
revisit bull thesi upgrad septemb
see great pbm disruptioncom great profit opportun
ep made top pick healthcar servic outlook see
underli driver under-penetrated carve-in pbm could
leverag brought in-hous drive servic medic growth
launch ingeniorx three quarter earli presenc
sell season see acceler thesi increas likelihood
gain share compar entri sell season ci
market messag would time matur post respect
merger carve-in rate well estim industri leader
unh/optumrx see signific upsid next sever year see exhibit
look ahead guidanc ep came well estim
discuss intern pbm start quarter
earli manag expect full run rate save
drop bottom line least full year earli model ep
assum growth exclud headwind return
hif continu momentum share view updat
discuss longer term growth rate investor day see
potenti sustain growth rate high-single-digit low-double-
digit revis upward low-double-digit low-teen rang
govern busi continu strength medicaid book
manag see strong enrol growth member year
ahead mn contract delay success began
compani includ new busi like not-yet-award
nc contract due could upsid earn ramp
success medicar advantag compani see strength
group individu combin membership growth
member individu book expect grow mid-double-digit
healthcar facil manag unit state
unless otherwis note metric base modelwar
consensu data provid thomson reuter estim
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
group busi reach target member
commerci book execut plan compani forecast
growth fully-insur busi midpoint tough
follow revamp compani sale strategi
manag also comment price remain disciplin
sacrif growth part success come better integr
commerci offer specialti product manag see clear
opportun cross-sel
model/pt updat updat model reflect result revis
guidanc includ time launch ingeniorx ep estim
goe vs consensu ep estim
goe vs consensu final
estim goe vs consensu pt goe
repres earn estim
think benefit ingeniorx first fulli begin realiz
exhibit pbm in-sourc ep sensit script penetr
note price pm
calcul price target appli price-to-earnings multipl
premium averag ntm multipl base case ep
discount back
bull case ep discount back year
bull case ep discount back year
pbm transit exce goal result increment enrol gain
membership accumul continu base busi pbm effici
drive greater pbm profit penetr base case
well health plan enrol growth bull case multipl halv
histor discount
base case ep discount back year
base case ep discount back year
penetr upsid transit pbm live esrx run smooth result
better penetr within health plan book medicare/medicaid capit
deploy acceler non-pbm growth base case price-to-earnings multipl
slight premium ntm price-to-earnings averag
bear case ep
bear case ep
failur execut pbm transit result lost profit opportun
enrol bear case multipl equal histor
averag growth slower
consist grown
membership past sever year
across self-fund fulli insur
transit in-hous pharmaci
benefit busi pbm express script
result signific profit opportun
inclus save better term
current contract well greater
medicar advantag medicaid
greater pbm effici well
come fail ci merger
flexibl deploy capit share
purchas
bp add ep
advantag bp add
updat pbm transit
risk achiev price
pbm transit delay poor execut
result lower profit lost member
capit deploy delay
price pressur govern
commerci busi result margin
sg expens net depreci
amort goodwill/intang
incom tax
incom non-recurring item
benefit expens ratio premium
sg net revenu
sg revenu way wlp guides/report
tax rate hif
